Anthony G. Pasqualone
Plus aucun poste en cours
Profil
Anthony G.
Pasqualone worked as Vice President-Strategic Markets at C.
R.
Bard, Inc. and as Vice President-Sales & Principal at Source Tech Medical LLC.
He also held managerial positions at Theragenics Corp.
and Calypso Medical Technologies, Inc. Additionally, he served as Vice President-Sales & Business Development at IsoRay, Inc. Pasqualone received his undergraduate degree from Fordham University.
Anciens postes connus de Anthony G. Pasqualone
| Sociétés | Poste | Fin |
|---|---|---|
Calypso Medical Technologies, Inc.
 Calypso Medical Technologies, Inc. Medical/Nursing ServicesHealth Services Calypso Medical Technologies, Inc. provided radiation therapy and medical services. The company was founded by Eric R. Meier, Alfred G. Merriweather and Steve Tallman in 1999 and was headquartered in Seattle, WA. | Corporate Officer/Principal | 01/11/2008 |
| C.R. BARD | Corporate Officer/Principal | 01/12/2005 |
Source Tech Medical LLC
 Source Tech Medical LLC Pharmaceuticals: MajorHealth Technology Part of Becton, Dickinson & Co., Source Tech Medical LLC is a company that develops, manufactures, and markets iodine radioactive isotope seeds for brachytherapy cancer treatment. The company is based in Carol Stream, IL. Source Tech Medical was acquired by C. R. Bard, Inc. (New Jersey), part of Becton, Dickinson & Co. from December 29, 2017 on June 16, 2003. | Sales & Marketing | 01/05/2003 |
Theragenics Corp.
 Theragenics Corp. Medical SpecialtiesHealth Technology Theragenics Corp. develops, manufactures and markets medical devices. It offers wound closure, vascular access, and specialty needle products. The company was founded in 1981 and is headquartered in Buford, GA. | Sales & Marketing | - |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Sales & Marketing | - |
Formation de Anthony G. Pasqualone
| Fordham University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Theragenics Corp.
Theragenics Corp. Medical SpecialtiesHealth Technology Theragenics Corp. develops, manufactures and markets medical devices. It offers wound closure, vascular access, and specialty needle products. The company was founded in 1981 and is headquartered in Buford, GA. | Health Technology |
Calypso Medical Technologies, Inc.
Calypso Medical Technologies, Inc. Medical/Nursing ServicesHealth Services Calypso Medical Technologies, Inc. provided radiation therapy and medical services. The company was founded by Eric R. Meier, Alfred G. Merriweather and Steve Tallman in 1999 and was headquartered in Seattle, WA. | Health Services |
Source Tech Medical LLC
Source Tech Medical LLC Pharmaceuticals: MajorHealth Technology Part of Becton, Dickinson & Co., Source Tech Medical LLC is a company that develops, manufactures, and markets iodine radioactive isotope seeds for brachytherapy cancer treatment. The company is based in Carol Stream, IL. Source Tech Medical was acquired by C. R. Bard, Inc. (New Jersey), part of Becton, Dickinson & Co. from December 29, 2017 on June 16, 2003. | Health Technology |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |